Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Testicular Neoplasms × Control Groups × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 3 Testicular Neoplasms 1 Motor Activity 1 Hyperthermia 1 Colorectal Neoplasms 1 Carcinoma 1

Interventions

Thiotepa 2 Peripheral Blood Stem Cell Transplantation 2 Paclitaxel 2 Ifosfamide 2 Flow Cytometry 2 Filgrastim 2 tremelimumab 1 thymoglobulin 1 pembrolizumab 1 palifosfamide lysine 1 isophosphamide mustard 1 durvalumab 1 Stem Cell Transplantation 1 Rituximab 1 Polymerase Chain Reaction 1 Mycophenolic Acid 1 Moxifloxacin 1 Melphalan 1 Immunoenzyme Techniques 1 Imatinib Mesylate 1 Histocompatibility Testing 1 Granulocyte Colony-Stimulating Factor 1 Gemcitabine 1 Etoposide 1 Epirubicin 1 Deferasirox 1 Data Collection 1 Cyproheptadine 1 Cyclophosphamide 1 Control Groups 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02577172 2017-01-26

TAST

Oslo University Hospital

Phase NA Terminated

Motor Activity, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡